Advertisement

Organisation › Details
Pfizer (Group)
At Pfizer (NYSE: PFE), we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world's best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. *
![]() |
Industry | pharmaceutical |
![]() |
Region | New York, NY |
Country | United States (USA) | |
Street | 235 East 42nd Street | |
City | 10017 New York, NY | |
Tel | +1-212-733-2323 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | USD | |
Annual sales | 48,613,000,000 (revenue, consolidated (2007) 2007-12-31) | |
Profit | 8,298,000,000 (2007-12-31) | |
* Document for �About Section�: | ||
Record changed: 2020-12-22 |
Advertisement

More documents for Pfizer (Group)
- [1] BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine". New York, NY & Mainz....
- [2] BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine". New York, NY & Mainz....
- [3] BioNTech SE. (12/19/20). "Press Release: Pfizer and BioNTech Receive Conditional Marketing Authorization by Swissmedic for COVID-19 Vaccine". Zürich & Mainz....
- [4] BioNTech SE. (12/11/20). "Press Release: Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19". New York, NY & Mainz....
- [5] MorphoSys AG. (12/1/20). "Press Release: Thomas Biegi Joins MorphoSys as Head of Corporate Communications". Planegg....
- [6] BioNTech SE. (11/9/20). "Press Release: Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study". New York, NY & Mainz....
- [7] BioNTech SE. (10/9/20). "Press Release: Pfizer Canada and BioNTech Initiate Rolling Submission to Health Canada for SARS-CoV-2 Vaccine Candidate BNT162b2". Kirkland, QC & Mainz....
- [8] BioNTech SE. (10/6/20). "Press Release: BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2". New York, NY & Mainz....
- [9] BioNTech SE. (7/27/20). "Press Release: BioNTech Announces Closing of $512 Million Underwritten Offering of American Depositary Shares". Mainz....
- [10] BioNTech SE. (7/27/20). "Press Release: Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study". New York, NY & Mainz....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top